| Dr Teresa Thuanh Phan, MD | |
|
41 S High St, Suite 25, Columbus, OH 43215-6101 | |
| (614) 533-6700 | |
| (614) 224-8562 |
| Full Name | Dr Teresa Thuanh Phan |
|---|---|
| Gender | Female |
| Speciality | Family Medicine |
| Location | 41 S High St, Columbus, Ohio |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003012907 | NPI | - | NPPES |
| 3082962 | Medicaid | OH |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 35.096152 (Ohio) | Primary |
| Entity Name | County Of San Mateo |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1679642326 PECOS PAC ID: 9032023171 Enrollment ID: O20031126000292 |
News Archive
Southern Research Institute today announced that it has been selected as one of 11 organizations to help establish the National Cancer Institute's (NCI) Chemical Biology Consortium (CBC)-a program meant to coordinate and accelerate the discovery and development of new therapeutic agents to treat cancer patients. Southern Research will establish one of NCI's five Comprehensive Chemical Biology Centers at its Birmingham campus.
A New York Medical College physician who specializes in restoring or preserving fertility in female cancer patients has discovered a possible link between the presence of breast cancer genes and infertility.
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.
A recently released Drug Diagnosis Coding database from RJ Health Systems provides accurate FDA-approved and Compendia-listed off-label uses for therapeutic classes such as Oncology, Anti-Emetics, Erythropoietin Stimulating Agents and Multiple Sclerosis Agents. The
› Verified 8 days ago
| Entity Name | Healthcare Partners Affiliates Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659312593 PECOS PAC ID: 7315842002 Enrollment ID: O20031204001258 |
News Archive
Southern Research Institute today announced that it has been selected as one of 11 organizations to help establish the National Cancer Institute's (NCI) Chemical Biology Consortium (CBC)-a program meant to coordinate and accelerate the discovery and development of new therapeutic agents to treat cancer patients. Southern Research will establish one of NCI's five Comprehensive Chemical Biology Centers at its Birmingham campus.
A New York Medical College physician who specializes in restoring or preserving fertility in female cancer patients has discovered a possible link between the presence of breast cancer genes and infertility.
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.
A recently released Drug Diagnosis Coding database from RJ Health Systems provides accurate FDA-approved and Compendia-listed off-label uses for therapeutic classes such as Oncology, Anti-Emetics, Erythropoietin Stimulating Agents and Multiple Sclerosis Agents. The
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Teresa Thuanh Phan, MD 5350 Frantz Rd, Dublin, OH 43016-4259 Ph: () - | Dr Teresa Thuanh Phan, MD 41 S High St, Suite 25, Columbus, OH 43215-6101 Ph: (614) 533-6700 |
News Archive
Southern Research Institute today announced that it has been selected as one of 11 organizations to help establish the National Cancer Institute's (NCI) Chemical Biology Consortium (CBC)-a program meant to coordinate and accelerate the discovery and development of new therapeutic agents to treat cancer patients. Southern Research will establish one of NCI's five Comprehensive Chemical Biology Centers at its Birmingham campus.
A New York Medical College physician who specializes in restoring or preserving fertility in female cancer patients has discovered a possible link between the presence of breast cancer genes and infertility.
The U.S. Food and Drug Administration has been investigating reports that patients undergoing computed tomography (CT) brain perfusion scans were accidently exposed to excess radiation. The FDA found that when properly used, the CT scanners did not malfunction. Instead, it is likely that the improper use of the scanners resulted in these overdoses. However, the FDA has identified a series or promising steps to enhance the safety of these procedures. These steps could reduce the likelihood of radiation overexposure in the event of improper use of the CT scanners.
RXi Pharmaceuticals Corporation, a biopharmaceutical company pursuing the development and commercialization of proprietary therapeutics based on RNA interference (RNAi), today announced that senior members of its management will be presenting at upcoming conferences and will highlight critical aspects of the development of RXi's next generation rxRNA™ therapeutic platform as well as specific preclinical data generated with this platform.
A recently released Drug Diagnosis Coding database from RJ Health Systems provides accurate FDA-approved and Compendia-listed off-label uses for therapeutic classes such as Oncology, Anti-Emetics, Erythropoietin Stimulating Agents and Multiple Sclerosis Agents. The
› Verified 8 days ago
Dr. Anne Marie Kessler, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 290 E Town St, Columbus, OH 43215 Phone: 614-788-5400 Fax: 614-788-5500 | |
Labronz C Davis, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2872 W Broad St, Columbus, OH 43204 Phone: 614-279-9905 Fax: 614-279-0213 | |
Dana S Vallangeon, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 524b W Broad St, Columbus, OH 43215 Phone: 614-225-0990 Fax: 614-225-0988 | |
Scott H Merryman, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3773 Olentangy River Rd, Columbus, OH 43214 Phone: 614-566-5356 Fax: 614-566-3835 | |
Karen Alice Clemency, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1020 Dennison Ave, Suite 200, Columbus, OH 43201 Phone: 614-564-9067 Fax: 614-564-9167 | |
Marc Evan Serve, D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1120 Polaris Pkwy Ste 200, Columbus, OH 43240 Phone: 614-880-9333 Fax: 614-880-9333 |